Rare Cancers

After a median follow-up of 9.9 months, 38% of the trial participants experienced some degree of tumor shrinkage after receiving Opdivo in combination with Yervoy.

New treatments are needed for penile cancer, but it’s difficult to test drugs in clinical trials because the disease is so uncommon.

A woman shares her late husband’s journey with advanced penile cancer to help others receive a diagnosis early, when the disease is still highly treatable and even curable.

In this episode of the “CURE Talks Cancer” podcast, we spoke with an expert about some of the possible causes of penile cancer, as well as why research in the field is severely lacking and why it’s so important to inform the public about what to look for in terms of signs and symptoms of this disease.

In this week’s episode of the CURE® Talks Cancer podcast, surgical oncologist Dr. Margo Shoup sits down with CURE® to shed some light on retroperitoneal sarcoma and shares her thoughts on what patients need to know about its diagnosis and treatment.

Salivary cancer is a rare disease that has some of the greatest variances of all types of cancer.

The PAN Foundation today opened a new patient assistance program for people living with carcinoid syndrome.

Two schools of thought exist about how to treat metastatic cancers of unidentified subtype, called carcinomas of unknown primary.

Patients with neuroendocrine tumors have more treatment options than ever before.

Fighting retroperitoneal sarcoma can be like fighting a rare and giant beast.